How Is Cellular Therapy Changing Care for Hematologic Malignancies?

By The Fellow on Call - Last Updated: October 10, 2023

In this episode of “The Fellow on Call,” hosts Ronak Mistry, DO; Vivek Patel, MD; and Dan Hausrath, MD; focus on cellular therapies for hematologic malignancies.

They highlight the latest research on chimeric antigen receptor (CAR) T-cell therapy, bispecific antibodies, and autologous hematopoietic stem cell transplantation (AHSCT). The hosts discuss key considerations surrounding CAR-T, including the manufacturing process, commercial CAR-T, as well as side effects and adverse events associated with CAR-T.

They also discuss the latest information on bispecific antibodies and how they fit into the treatment paradigm. Additionally, they speak about the role of AHSCT in lymphoma.

This podcast originally appeared on

Editorial Board